Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor

Recent developments in cancer treatment are demonstrating the increasing and powerful potential of immunotherapeutic strategies. In this regard, the adoptive transfer of tumor-specific T-lymphocytes approaches can lead to tumor regression in cancer patients. More recently, the use of T-cells genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisenberg, Vasyl, Shamalov, Katerina, Meir, Shimrit, Hoogi, Shiran, Sarkar, Rhitajit, Pinker, Shirel, Markel, Gal, Porgador, Angel, Cohen, Cyrille J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649149/
https://www.ncbi.nlm.nih.gov/pubmed/29085357
http://dx.doi.org/10.3389/fimmu.2017.01212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649149/
https://www.ncbi.nlm.nih.gov/pubmed/29085357
http://dx.doi.org/10.3389/fimmu.2017.01212

Ejemplares similares